Hyaluronan's role in fibrosis: A pathogenic factor or a passive player?

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Albeiroti, Sami ^a   Soroosh, Artin ^a   De La Motte, Carol A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; HYALURONIC ACID; TRANSFORMING GROWTH FACTOR BETA; ACTIN; TRANSFORMING GROWTH FACTOR BETA1;

CELL FUNCTION; DISEASE ASSOCIATION; ENZYME DEGRADATION; EXTRACELLULAR MATRIX; FIBROSIS; HUMAN; INFLAMMATION; MYOFIBROBLAST; NONHUMAN; PATHOGENESIS; REVIEW; WOUND HEALING; FIBROBLAST; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ACTINS; COLLAGEN; EXTRACELLULAR MATRIX; FIBROBLASTS; FIBROSIS; HUMANS; HYALURONIC ACID; MYOFIBROBLASTS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84947465909     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/790203     Document Type: Review

References (76)

1. J. Halper and M. Kjaer, "Basic components of connective tissues and extracellular matrix: elastin, fbrillin, fbulins, fb-rinogen, fbronectin, laminin, tenascins and thrombospondins," Advances in Experimental Medicine and Biology, vol. 802, pp. 31-47, 2014.
2. T. R. Cox and J. T. Erler, "Remodeling and homeostasis of the extracellular matrix: implications for fbrotic diseases and cancer," Disease Models & Mechanisms, vol. 4, no. 2, pp. 165-178, 2011.
3. F. Rieder and C. Fiocchi, "Intestinal fbrosis in IBD-a dynamic, multifactorial process," Nature Reviews Gastroenterology and Hepatology, vol. 6, no. 4, pp. 228-235, 2009.
4. C. Bonnans, J. Chou, and Z. Werb, "Remodelling the extracellular matrix in development and disease," Nature Reviews Molecular Cell Biology, vol. 15, no. 12, pp. 786-801, 2014.
5. B. Hinz, S. H. Phan, V. J. Tannickal, A. Galli, M.-L. Bochaton-Piallat, and G. Gabbiani, "The my of broblast: one function, multiple origins," The American Journal of Pathology, vol. 170, no. 6, pp. 1807-1816, 2007.
6. J. Baum and H. S. Dufy, "Fibroblasts and my of broblasts: what are we talking about?" Journal of Cardiovascular Pharmacology, vol. 57, no. 4, pp. 376-379, 2011.
7. V. S. Rajkumar, X. Shiwen, M. Bostrom et al., "Platelet-derived growth factor-β receptor activation is essential for fbroblast and pericyte recruitment during cutaneous wound healing," American Journal of Pathology, vol. 169, no. 6, pp. 2254-2265, 2006.
8. D. E. Sullivan, M. Ferris, H. Nguyen, E. Abboud, and A. R. Brody, "TNF-β induces TGF-β1 expression in lung fbroblasts at the transcriptional level via AP-1 activation," Journal of Cellular and Molecular Medicine, vol. 13, no. 8, pp. 1866-1876, 2009.
9. J. E. Kolodsick, G. B. Toews, C. Jakubzick et al., "Protection from fuorescein isothiocyanate-induced fbrosis in IL-13-defcient, but not IL-4-defcient, mice results from impaired collagen synthesis by fbroblasts," The Journal of Immunology, vol. 172, no. 7, pp. 4068-4076, 2004.
10. T. Mchedlidze, M. Waldner, S. Zopf et al., "Interleukin-33-dependent innate lymphoid cells mediate hepatic fbrosis," Immunity, vol. 39, no. 2, pp. 357-371, 2013.
11. A. Leask and D. J. Abraham, "TGF-β signaling and the fbrotic response," The FASEB Journal, vol. 18, no. 7, pp. 816-827, 2004.
12. F. Verrecchia, M.-L. Chu, and A. Mauviel, "Identifcation of novel TGF-β/Smad gene targets in dermal fbroblasts using a combined cDNA microarray/promoter transactivation approach," The Journal of Biological Chemistry, vol. 276, no. 20, pp. 17058-17062, 2001.
13. G. Serini, M.-L. Bochaton-Piallat, P. Ropraz et al., "The fbronectin domain ED-A is crucial for my of broblastic pheno-type induction by transforming growth factor-β1," Journal of Cell Biology, vol. 142, no. 3, pp. 873-881, 1998.
14. S. Bhattacharyya, Z. Tamaki, W. Wang et al., "FibronectinEDA promotes chronic cutaneous fbrosis through toll-like receptor signaling," Science Translational Medicine, vol. 6, no. 232, Article ID 232ra50, 2014.
15. K. E. Lipson, C. Wong, Y. Teng, and S. Spong, "CTGF is a central mediator of tissue remodeling and fbrosis and its inhibition can reverse the process of fbrosis," Fibrogenesis & Tissue Repair, vol. 5, supplement 1, article S24, 2012.
16. E. S. Bensadoun, A. K. Burke, J. C. Hogg, and C. R. Roberts, "Proteoglycan deposition in pulmonary fbrosis," The American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 6, pp. 1819-1828, 1996.
17. G. Westergren-Torsson, J. Hernnäs, B. Särnstrand, Å. Oldberg, D. Heinegård, and A. Malmström, "Altered expression of small proteoglycans, collagen, and transforming growth factor-β1 in developing bleomycin-induced pulmonary fbrosis in rats," The Journal of Clinical Investigation, vol. 92, no. 2, pp. 632-637, 1993.
18. N. Venkatesan, T. Ebihara, P. J. Roughley, and M. S. Ludwig, "Alterations in large and small proteoglycans in bleomycin-induced pulmonary fbrosis in rats," American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 6, pp. 2066-2073, 2000.
19. T. Ebihara, N. Venkatesan, R. Tanaka, and M. S. Ludwig, "Changes in extracellular matrix and tissue viscoelasticity in bleomycin-induced lung fbrosis: temporal aspects," American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 4, pp. 1569-1576, 2000.
20. N. Venkatesan, K. Tsuchiya, M. Kolb et al., "Glycosyltrans-ferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fbrosis," American Journal of Respiratory Cell and Molecular Biology, vol. 50, no. 3, pp. 583-594, 2014.
21. B. P. Toole, "Hyaluronan: from extracellular glue to pericellular cue," Nature Reviews Cancer, vol. 4, no. 7, pp. 528-539, 2004.
22. N. Itano and K. Kimata, "Mammalian hyaluronan synthases," IUBMB Life, vol. 54, no. 4, pp. 195-199, 2002.
23. D. Vigetti, E. Karousou, M. Viola, S. Deleonibus, G. de Luca, and A. Passi, "Hyaluronan: biosynthesis and signaling," Biochimica et Biophysica Acta, vol. 1840, no. 8, pp. 2452-2459, 2014.
24. Y. Wang, M. E. Lauer, S. Anand, J. A. Mack, and E. V. Maytin, "Hyaluronan synthase 2 protects skin fbroblasts against apop-tosis induced by environmental stress," The Journal of Biological Chemistry, vol. 289, no. 46, pp. 32253-32265, 2014.
25. D. Kohda, C. J. Morton, A. A. Parkar et al., "Solution structure of the link module: a hyaluronan-binding domain involved in extracellular matrix stability and cell migration," Cell, vol. 86, no. 5, pp. 767-775, 1996.
26. D. Naor, R. V. Sionov, and D. Ish-Shalom, "CD44: structure, function, and association with the malignant process," Advances in Cancer Research, vol. 71, pp. 241-319, 1997.
27. A. B. Csoka, G. I. Frost, and R. Stern, "The six hyaluronidase-like genes in the human and mouse genomes," Matrix Biology, vol. 20, no. 8, pp. 499-508, 2001.
28. T. Kaneiwa, S. Mizumoto, K. Sugahara, and S. Yamada, "Identif-cation of human hyaluronidase-4 as a novel chondroitin sulfate hydrolase that preferentially cleaves the galactosaminidic linkage in the trisulfated tetrasaccharide sequence," Glycobiology, vol. 20, no. 3, pp. 300-309, 2010.
29. M. De Salegui and W. Pigman, "The existence of an acid-active hyaluronidase in serum," Archives of Biochemistry and Biophysics, vol. 120, no. 1, pp. 60-67, 1967.
30. B. Triggs-Raine, T. J. Salo, H. Zhang, B. A. Wicklow, and M. R. Natowicz, "Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, muco-polysaccharidosis IX," Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 11, pp. 6296-6300, 1999.
31. S. Albeiroti, K. Ayasouf, D. R. Hill, B. Shen, and C. A. de la Motte, "Platelet hyaluronidase-2: an enzyme that translocates to the surface upon activation to function in extracellular matrix degradation," Blood, vol. 125, no. 9, pp. 1460-1469, 2015.
32. R. Stern and M. J. Jedrzejas, "Hyaluronidases: their genomics, structures, and mechanisms of action," Chemical Reviews, vol. 106, no. 3, pp. 818-839, 2006.
33. + exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion," Journal of Biological Chemistry, vol. 279, no. 26, pp. 26991-27007, 2004.
34. H. Harada and M. Takahashi, "CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluroni-dase-1 and -2," The Journal of Biological Chemistry, vol. 282, no. 8, pp. 5597-5607, 2007.
35. M. E. Monzon, N. Fregien, N. Schmid et al., "Reactive oxygen species and hyaluronidase 2 regulate airway epithelial hyaluro-nan fragmentation," The Journal of Biological Chemistry, vol. 285, no. 34, pp. 26126-26134, 2010.
36. J. Guechot, A. Loria, L. Serfaty, P. Giral, J. Giboudeau, and R. Poupon, "Serum hyaluronan as a marker of liver fbrosis in chronic viral hepatitis C: efect of α-interferon therapy," Journal of Hepatology, vol. 22, no. 1, pp. 22-26, 1995.
37. J. Liang, D. Jiang, Y. Jung et al., "Role of hyaluronan and hya-luronan-binding proteins in human asthma," Journal of Allergy and Clinical Immunology, vol. 128, no. 2, pp. 403-411.e3, 2011.
38. S. Kessler, H. Rho, G. West, C. Fiocchi, J. Drazba, and C. de la Motte, "Hyaluronan (HA) deposition precedes and promotes leukocyte recruitment in intestinal infammation," Clinical and Translational Science, vol. 1, no. 1, pp. 57-61, 2008.
39. M. Aytekin, S. A. A. Comhair, C. de la Motte et al., "High levels of hyaluronan in idiopathic pulmonary arterial hypertension," The American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 295, no. 5, pp. L789-L799, 2008.
40. G. M. Campo, A. Avenoso, A. D,Ascola et al., "Hyaluronan diferently modulates TLR-4 and the infammatory response in mouse chondrocytes," BioFactors, vol. 38, no. 1, pp. 69-76, 2012.
41. R. Stern, A. A. Asari, and K. N. Sugahara, "Hyaluronan fragments: an information-rich system," European Journal of Cell Biology, vol. 85, no. 8, pp. 699-715, 2006.
42. A. C. Petrey and C. A. de la Motte, "Hyaluronan, a crucial regulator of infammation," Frontiers in Immunology, vol. 5, article 101, 2014.
43. K. Nakamura, S. Yokohama, M. Yoneda et al., "High, but not low, molecular weight hyaluronan prevents T-cell-mediated liver injury by reducing proinfammatory cytokines in mice," Journal of Gastroenterology, vol. 39, no. 4, pp. 346-354, 2004.
44. P. Teder, R. W. Vandivier, D. Jiang et al., "Resolution of lung infammation by CD44," Science, vol. 296, no. 5565, pp. 155-158, 2002.
45. + regulatory T cells," The Journal of Immunology, vol. 179, no. 2, pp. 744-747, 2007.
46. D. R. Hill, S. P. Kessler, H. K. Rho, M. K. Cowman, and C. A. de la Motte, "Specifc-sized hyaluronan fragments promote expression of human β-defensin 2 in intestinal epithelium," The Journal of Biological Chemistry, vol. 287, no. 36, pp. 30610-30624, 2012.
47. M. E. Lauer, T. T. Glant, K. Mikecz et al., "Irreversible heavy chain transfer to hyaluronan oligosaccharides by tumor necrosis factor-stimulated gene-6," The Journal of Biological Chemistry, vol. 288, no. 1, pp. 205-214, 2013.
48. M. Zhao, M. Yoneda, Y. Ohashi et al., "Evidence for the covalent binding of SHAP, heavy chains of inter-α-trypsin inhibitor, to hyaluronan," The Journal of Biological Chemistry, vol. 270, no. 44, pp. 26657-26663, 1995.
49. C. A. de la Motte, V. C. Hascall, J. Drazba, S. K. Bandyopad-hyay, and S. A. Strong, "Mononuclear leukocytes bind to spe-cifc hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: inter-α-trypsin inhibitor is crucial to structure and function," The American Journal of Pathology, vol. 163, no. 1, pp. 121-133, 2003.
50. L. Bjermer, R. Lundgren, and R. Hallgren, "Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fuid in idiopathic pulmonary fbrosis," Torax, vol. 44, no. 2, pp. 126-131, 1989.
51. J. Hernnas, O. Nettelbladt, L. Bjermer, B. Särnstrand, A. Malm-ström, and R. Hällgren, "Alveolar accumulation of fbronectin and hyaluronan precedes bleomyin-induced pulmonary fbrosis in the rat," European Respiratory Journal, vol. 5, no. 4, pp. 404-410, 1992.
52. P. Halfon, M. Bourlière, G. Pénaranda et al., "Accuracy of hyaluronic acid level for predicting liver fbrosis stages in patients with hepatitis C virus," Comparative Hepatology, vol. 4, article 6, 2005.
53. J. Gúechot, A. Loria, L. Serfaty, P. Giral, J. Giboudeau, and R. Poupon, "Serum hyaluronan as a marker of liver fbrosis in chronic viral hepatitis C: efect of α-interferon therapy," Journal of Hepatology, vol. 22, no. 1, pp. 22-26, 1995.
54. B. P. Toole, S. I. Munaim, S. Welles, and C. B. Knudson, "Hyaluronate-cell interactions and growth factor regulation of hyaluronate synthesis during limb development," Ciba Foundation symposium, vol. 143, pp. 138-145, 1989.
55. P. Heldin, T. C. Laurent, and C.-H. Heldin, "Efect of growth factors on hyaluronan synthesis in cultured human fbroblasts," Biochemical Journal, vol. 258, no. 3, pp. 919-922, 1989.
56. G. Westergren-Torsson, B. Särnstrand, L.-A. Fransson, and A. Malmström, "TGF-β enhances the production of hyaluronan in human lung but not in skin fbroblasts," Experimental Cell Research, vol. 186, no. 1, pp. 192-195, 1990.
57. B. A. Dubaybo and L. A. Tet, "Efect of transforming growth factor beta on synthesis of glycosaminoglycans by human lung fbroblasts," Experimental Lung Research, vol. 16, no. 5, pp. 389-403, 1990.
58. Y. Sugiyama, A. Shimada, T. Sayo, S. Sakai, and S. Inoue, "Putative hyaluronan synthase mRNA are expressed in mouse skin and TGF-β upregulates their expression in cultured human skin cells," Journal of Investigative Dermatology, vol. 110, no. 2, pp. 116-121, 1998.
59. I. R. Ellis and S. L. Schor, "Diferential efects of TGF-β1 on hyaluronan synthesis by fetal and adult skin fbroblasts: implications for cell migration and wound healing," Experimental Cell Research, vol. 228, no. 2, pp. 326-333, 1996.
60. K. M. Stuhlmeier and C. Pollaschek, "Diferential efect of transforming growth factor beta (TGF-beta) on the genes encoding hyaluronan synthases and utilization of the p38 MAPK pathway in TGF-beta-induced hyaluronan synthase 1 activation," Journal of Biological Chemistry, vol. 279, no. 10, pp. 8753-8760, 2004.
61. S. K. Samuel, R. A. R. Hurta, M. A. Spearman, J. A. Wright, E. A. Turley, and A. H. Greenberg, "TGF-β1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan," The Journal of Cell Biology, vol. 123, no. 3, pp. 749-758, 1993.
62. C. Tolg, S. R. Hamilton, E. Zalinska et al., "A RHAMM mimetic peptide blocks hyaluronan signaling and reduces infammation and fbrogenesis in excisional skin wounds," American Journal of Pathology, vol. 181, no. 4, pp. 1250-1270, 2012.
63. T. Ito, J. D. Williams, S. Al-Assaf, G. O. Phillips, and A. O. Phillips, "Hyaluronan and proximal tubular cell migration," Kidney International, vol. 65, no. 3, pp. 823-833, 2004.
64. D. H. Han, H. K. Song, S. Y. Lee et al., "Upregulation of hya-luronan and its binding receptors in an experimental model of chronic cyclosporine nephropathy," Nephrology, vol. 15, no. 2, pp. 216-224, 2010.
65. N. Kato, T. Kosugi, W. Sato et al., "Basigin/CD147 promotes renal fbrosis afer unilateral ureteral obstruction," American Journal of Pathology, vol. 178, no. 2, pp. 572-579, 2011.
66. V. Colombaro, I. Jadot, A. E. Declèves et al., "Lack of hya-luronidases exacerbates renal post-ischemic injury, infamma-tion, and fbrosis," Kidney International, 2015.
67. S. Meran, D. W. Tomas, P. Stephens et al., "Hyaluronan facilitates transforming growth factor-β1-mediated fbroblast proliferation," The Journal of Biological Chemistry, vol. 283, no. 10, pp. 6530-6545, 2008.
68. S. Meran, D. D. Luo, R. Simpson et al., "Hyaluronan facilitates transforming growth factor-β1-dependent proliferation via CD44 and epidermal growth factor receptor interaction," The Journal of Biological Chemistry, vol. 286, no. 20, pp. 17618-17630, 2011.
69. A. C. Midgley, M. Rogers, M. B. Hallett et al., "Transforming growth factor-β1 (TGF-β1)-stimulated fbroblast to myofbrob-last diferentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafs," Journal of Biological Chemistry, vol. 288, no. 21, pp. 14824-14838, 2013.
70. A. C. Midgley, L. Duggal, R. Jenkins et al., "Hyaluronan regulates bone morphogenetic protein-7-dependent prevention and reversal of my of broblast phenotype," Journal of Biological Chemistry, vol. 290, no. 18, pp. 11218-11234, 2015.
71. Y. Li, D. Jiang, J. Liang et al., "Severe lung fbrosis requires an invasive fbroblast phenotype regulated by hyaluronan and CD44," Journal of Experimental Medicine, vol. 208, no. 7, pp. 1459-1471, 2011.
72. S. P. Evanko, S. Potter-Perigo, L. J. Petty, G. A. Workman, and T. N. Wight, "Hyaluronan controls the deposition of fbro-nectin and collagen and modulates TGF-β1 induction of lung my of broblasts," Matrix Biology, vol. 42, pp. 74-92, 2015.
73. J. Li, D. J. Gorski, W. Anemaet et al., "Hyaluronan injection in murine osteoarthritis prevents TGFbeta 1-induced synovial neovascularization and fbrosis and maintains articular cartilage integrity by a CD44-dependent mechanism," Arthritis Research and Terapy, vol. 14, no. 3, article R151, 2012.
74. C. Tolg, P. Telmer, E. Turley, and P. Mukhopadhyay, "Specifc sizes of hyaluronan oligosaccharides stimulate fbroblast migration and excisional wound repair," PLoS ONE, vol. 9, no. 2, Article ID e88479, 2014.
75. M. David-Raoudi, F. Tranchepain, B. Deschrevel et al., "Differential efects of hyaluronan and its fragments on fbroblasts: relation to wound healing," Wound Repair and Regeneration, vol. 16, no. 2, pp. 274-287, 2008.
76. P. Rooney, M. Wang, P. Kumar, and S. Kumar, "Angiogenic oligosaccharides of hyaluronan enhance the production of collagens by endothelial cells," The Journal of Cell Science, vol. 105, part 1, pp. 213-218, 1993.